Company Website:
http://www.johnsonandweaver.com
SAN DIEGO -- (Business Wire)
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating
potential violations of the federal securities laws by Roka Bioscience,
Inc. (NASDAQ: ROKA) and certain of its officers. Roka Bioscience is a
molecular diagnostics Company focusing on the development and
commercialization of molecular assay technologies for the detection of
foodborne pathogens.
Specifically, Johnson & Weaver’s investigation seeks to determine
whether certain statements regarding the Company’s business and
prospects were false and misleading when made.
On July 17, 2014 Roka Bioscience stock opened for trading at $12.00 the
day the Company sold 5.0 million shares of stock in its initial public
stock offering (the “IPO”), reaching a high of $13.00 per share the
following day. However, just several months after its IPO, on November
6, 2014, the company announced that it lost 64 cents a share in the
third quarter. Additionally, the Company reported that there were no
new Atlas® instruments placements made during the quarter. This news
sent the Company’s stock price plummeting, closing at $3.00 per share on
November 7, 2014, a decline of $5.34 per share or 64%.
If you have information that could assist in this investigation, or
if you are a Roka Bioscience shareholder and are interested in learning
more about the investigation or your legal rights and remedies, please
contact Jim Baker (jimb@johnsonandweaver.com) by
email or by phone at 619-814-4471. If emailing, please include a phone
number where you can be reached.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law
firm with offices in California, New York and Georgia. The firm
represents individual and institutional investors in shareholder
derivative and securities class action lawsuits. For more information
about the firm and its attorneys, please visit http://www.johnsonandweaver.com.
Attorney advertising. Past results do not guarantee future outcomes.
Contacts:
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com
Source: Johnson & Weaver, LLP
© 2024 Canjex Publishing Ltd. All rights reserved.